Advanced Enzyme Technologies Limited Investor Presentation | May 2017
Disclaimer This information may contain certain forward-looking statements/details in the current scenario, which is extremely dynamic and increasingly fraught with risks and uncertainties. Actual results, performances, achievements or sequence of events may be materially different from the views expressed herein. Investors/shareholders/public are hence cautioned not to place undue reliance on these statements/details, and are advised to conduct their own investigation and analysis of the information contained or referred to in this section be fore taking any action with regard to their own specific objectives. Further, the discussion following here in reflects the perceptions on major issues as on date and the opinions expressed here are subject to change without notice. The Company under takes no obligation to publicly update or revise any of the opinions or forward-looking statements expressed in this section, consequent to new information, future events or otherwise. Investor Presentation | May 2017 2
Content Company Overview 4 Global Enzyme Market 13 Advanced Enzymes - A Unique 16 Investment Case Future Growth Strategies & 25 Pipeline Financial Overview 29 3
Company Overview Investor Presentation | May 2017 4
Company Overview What are enzymes? Company Overview Advanced Enzymes is a research driven company with global leadership in the manufacturing of enzymes. We are committed to providing eco-safe solutions Enzymes are natural protein to a wide variety of industries like human health care and nutrition, animal molecules that act as catalysts nutrition, baking, fruit & vegetable processing, brewing & malting, grain processing, protein modification, dairy processing, speciality applications, within living cells, produced by all textile processing and others. Our aim is to replace traditionally used living organisms. Function as chemicals with eco-friendly enzymatic solutions. specialized catalysts and accelerate Mission the pace of biochemical reactions. Advanced uses enzymes to replace It is our mission to see that every human being is able to take advantage of the power of enzymes for well-being and leading chemicals in, and improve a healthy life! efficiency of, a wide variety of Vision industrial processes for its customers. Our vision at Advanced Enzymes is to become the leading, enzyme-based, value provider to consumers and Bio- Processors globally! Investor Presentation | May 2017 5
Board of Directors Mr. Vasant Rathi Mr. C L Rathi Chairman and Non-Executive Director Managing Director Mr. Vasant Laxminarayan Rathi is the Promoter Chairman and Non- Mr. Chandrakant Laxminarayan Rathi, is the Promoter and Executive Director of our Company. He promoted & incorporated Managing Director of our Company. He is currently responsible for Cal-India in the year 1985 and has been associated with our the management of the entire operations of the Company and its Company since the year 1993. Mr. Rathi heads our international Indian subsidiaries, including strategic initiatives of our businesses. subsidiaries based in US. Mrs. Savita Rathi Mr. Mukund M. Kabra Whole-time Director Whole-time Director Mrs. Savita Chandrakant Rathi, is the Whole-time Director of our Mr. Mukund Madhusudan Kabra, is the Whole-time Director of our Company. She is responsible for the administration of the Company, Company. He is responsible for overlooking the manufacturing management and supervision of Export-Import, Client relationship operations of the Company at Sinnar and Indore and for optimising management and the Human Resource department of the the fermentation for existing products, strain improvement, Company. downstream research and analytical research. Mrs. Rupa Vora Mr. Kedar Desai Independent Director Independent Director Mrs. Rupa Rajul Vora, is a Non-Executive and Independent Director Mr. Kedar Jagdish Desai, is the Independent Director on our Board. of our Company since November 28, 2015. She was the Chief He holds a Bachelor’s degree in Commerce and Law from the Financial Officer at Antwerp Diamond Bank N.V., after which she University of Mumbai. He is also a qualified solicitor from the joined IDFC Group as a Group Director and Chief Financial Officer- Bombay Incorporated Law Society and has over 19 years of Alternatives until June 2014. Currently, she serves as an experience in the field of law. independent director on a few corporate boards. Mr. Pramod Kasat Mr. Ramesh Mehta Independent Director Independent Director Mr. Ramesh Thakorlal Mehta is a Non-Executive and Independent Mr. Pramod Kasat, is a Non-Executive and Independent Director of our Company since December 14, 2016. He is currently the Country Director of our Company since 1993. He has experience in the Head â €“ Investment banking , Indusind Bank, Mumbai. business of jewellery designing and manufacturing. Investor Presentation | May 2017 6
Management Team Piyush Rathi Beni Prasad Rauka Dr. Anil Gupta Dipak Roda Vice President Vice President Chief Business Officer Chief Financial Officer Market & Business Development Research & Development A double graduate, Piyush first Mr. Beni Prasad Rauka, a Chartered Dr. Anil Gupta is a Ph.D. in After having secured a Chemical completed his Bachelors in Maths from Accountant and Company Secretary by Microbiology with over 18 years of Engineering degree from Bharati Mumbai University and then in Finance qualification, brings with him a rich experience in Industrial Biotechnology. Vidyapeeth, Pune and a M.Sc. Tech in from Michigan Tech University, USA. experience of over 24 years in the Prior to his joining Advanced Enzymes, Bioprocess Technology from UDCT, Mr. Subsequently he completed his MBA Finance Industry. Mr. Rauka has he also received the coveted Young Dipak Roda began his career with from SCMHRD and joined Advanced worked with Category I Merchant Scientist Award Project from Khandelwal Laboratories in their bio- Enzymes in April 2005. In 2007 and in Banking firms and finance companies in Department of Science & Technology, technology division. Mr. Roda joined 2010, Piyush took charge of the Human his long standing career. Mr Rauka Govt. Of India and has worked as Advanced Enzymes in 2005 as a Nutrition and Bio-Processing joined Advanced Enzymes in the year Principal Investigator in several General Manager in Sales & Marketing. businesses respectively, and since 2000 as a consultant. Rauka has been research projects. Today, as Vice He played a key role in aligning the 2014, he has also started developing leading the financial innovation in the President - Research & Development, product baskets to the respective the Animal Nutrition business new business structure and managing General Manager Research & industries that they catered to. He led internationally. Today, as Chief the financial activities of all group Development, Dr. Gupta heads the the company's entry into the large and Business Officer, his key responsibility companies since 2007. As Group CFO, process development, proteomics & competitive Chinese market through is to oversee the development of the his prime objective today is to ensure the applied microbiology labs and leads establishment of Advanced Enzyme Far company's business in Europe & Asia. that adequate and cost-effective the research effort in developing East. Today, his focus is on growing the He has also been instrumental in the finance is available for the group's several new commercially-viable bio-processing business in the recent acquisition of JC Biotech. strategic plans and investments. enzymes every year. American continents and his key challenge is to build a strong marketing, sales & distribution network there. Investor Presentation | May 2017 7
Advanced Enzyme Technologies Limited – A Rising Global Star Revenue (₹ mn) Indian enzyme company 1 st Highest market share in India Listed pure enzyme player globally 2 nd 2 nd 3,314 2,204 Amongst Top 15 Global Enzyme Companies Manufacturing Units – 7 R&D Units – 5 FY 2013 FY 2017 India - 5 USA - 2 India - 4 USA - 1 EBIDTA (₹ mn) 1,530 943 65+ 400+ 700+ 45+ 22+ FY 2013 FY 2017 Indigenously Proprietary Products Customers International Years of Developed Enzymes Worldwide Presence Fermentation & Probiotics Experience PAT (₹ mn) 924 13 11 1 420 500+ 509 m 3 Fermentation Registered Patents* Food Enzyme GRAS Dossier filed Employees Dossiers filed with with US FDA Capacity FY 2013 FY 2017 EFSA* * As on the date of RHP Investor Presentation | May 2017 8
Geographical Presence International Presence Manufacturing Facilities – 7 INDIA Thane 1 Nasik 2 Indore 1 Ongole 1 USA Chino 2 R&D Centres - 5 INDIA Thane 2 Sinnar 1 Ongole 1 USA Chino 1 Investor Presentation | May 2017 9
Recommend
More recommend
